Protalix BioTherapeutics (PLX) Misses Q3 EPS by 9c; Reports Cash and Cash Equivalents of $48.7M
Go back to Protalix BioTherapeutics (PLX) Misses Q3 EPS by 9c; Reports Cash and Cash Equivalents of $48.7M| PROTALIX BIOTHERAPEUTICS, INC. COMMON STOCK (NYSE: PLX) | Delayed: 2.16 -0.06 (2.7%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.22 | 52 Week High | $1.11 | |||
| Open | $2.21 | 52 Week Low | $0.41 | |||
| Day High | $2.27 | P/E | N/A | |||
| Day Low | $2.14 | EPS | $-0.29 | |||
| Volume | 723,304 | |||||
